Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
about
Impairment of PTX3 expression in osteoblasts: a key element for osteoporosis.Comparison of tissue transglutaminase 2 and bone biological markers osteocalcin, osteopontin and sclerostin expression in human osteoporosis and osteoarthritis.Heavy metals accumulation affects bone microarchitecture in osteoporotic patients.
P2860
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
@ast
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
@en
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
@nl
type
label
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
@ast
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
@en
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
@nl
prefLabel
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
@ast
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
@en
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.
@nl
P2093
P2860
P50
P356
P1476
Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations
@en
P2093
Cecilia Rao
Elena Gasbarra
Irene Cerocchi
Monica Celi
Umberto Tarantino
P2860
P304
P356
10.1155/2014/372021
P577
2014-04-14T00:00:00Z